Cancer Research Horizons
Overview
Cancer Research Horizons is the innovation arm of Cancer Research UK, operating as a specialist oncology drug discovery, development, and commercialization firm that invests in early-stage ventures to translate scientific breakthroughs into patient treatments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Laigo Bio | Mar 2026 | Seed | Co-investor |
| ALTx Therapeutics | Feb 2026 | Accelerator | Co-investor |
| Infinitopes Precision Immunomics | Jan 2026 | Seed | Co-investor |
| Trogenix | Oct 2025 | Series A | Co-investor |
| AiM Medical Robotics | Sep 2025 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cancer Research Horizons based?
Cancer Research Horizons is headquartered in London, United Kingdom.
When was Cancer Research Horizons founded?
Cancer Research Horizons was founded in 1982.
How many portfolio companies does Cancer Research Horizons have?
Cancer Research Horizons has 23 portfolio companies in Caplight's dataset.
What are some companies in Cancer Research Horizons's portfolio?
Recent investments visible on Caplight include Laigo Bio, ALTx Therapeutics, Infinitopes Precision Immunomics, Trogenix, AiM Medical Robotics.
What was Cancer Research Horizons's most recent investment?
Cancer Research Horizons's most recent investment on Caplight was in Laigo Bio in 2026.
What sectors does Cancer Research Horizons focus on?
Cancer Research Horizons focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Cancer Research Horizons focus on?
Cancer Research Horizons typically invests at the Early stage.
What is Cancer Research Horizons's AUM?
Cancer Research Horizons's assets under management are estimated between $38.1M and $38.1M.